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Chapter 11
Hypotensive Hemostasis in Patients Presenting 
with Ruptured Aortic Aneurysm
Felice Pecoraro, Bernard Krüger, Johnny Steuer, Neal Cayne,  
Zoran Rancic, Frank J. Veith, and Mario Lachat
 Introduction
In contrast to peripheral vascular injury, which may be controlled with a tourniquet 
or manual compression to stabilize the patient before definitive repair, in the rup-
tured intrathoracic and intra-abdominal aorta or its branches, external compression 
is rarely an alternative. Acute and severe blood loss leads to hypotension and car-
diovascular shock, resulting in multisystem organ failure and eventual death. 
However, aggressive fluid resuscitation in these patients can be detrimental as 
large-volume infusion may lead to further blood loss, hemodilution [1], dilutional 
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coagulopathy, and hypothermia [2]. Moreover, in ruptured abdominal aortic 
 aneurysm (rAAA), massive retroperitoneal bleeding contributes to the development 
of intra-abdominal hypertension (IAH) and ultimately to abdominal compartment 
syndrome (ACS) with a high risk of severe complications and death [3]. Finally, 
massive transfusion of red blood cells, thrombocytes, and/or coagulation factors 
may be accompanied by severe immunologic reaction and transfusion-related acute 
lung injury (TRALI) [4]. To avoid these scenarios and/or complications, hypoten-
sive hemostasis is advocated.
From a historical point of view, in 1949 Andresen et al. reported their  experience 
in the management of gastric hemorrhage suggesting that “No transfusion should 
be given in the first days except for evidence of severe anoxia. Then try 1 or 2 
transfusions of 150–200 CC of citrated blood” [5]. This original experience first 
advised a switch from resuscitation with high amount of fluids to achieve a neo-
physiological blood pressure to the concept of hypotensive hemostasis, limiting 
the resuscitation fluids in cases of massive blood loss. In 1981, Akins showed in 
an observational single-center study that in patients with blunt aortic injury, the 
use of beta-blockers and antihypertensive therapy permitted stabilizing the patient 
to allow delayed aortic repair until extracorporeal circulation with the use of a 
heart-lung machine could be initiated, which was often a necessity in the era pre-
ceding the current use of endovascular aneurysm repair (EVAR) [6]. In 1991 
Crawford [7] advocated, in patients presenting with rAAA, the use of small vol-
umes of whole blood or crystalloid to maintain blood pressure around 50–70 mmHg 
until cross-clamping of the aorta was accomplished. A similar fluid restriction 
scheme was reported in 2002 by Veith and Ohki [8] for EVAR in rAAA. Controlled 
hypotension using vasodilators to lower the blood pressure to <100 mmHg was 
reported first by our group in 2002 and later by Yilmaz et al. [9]. In 2007 
Blankensteijn confirmed in a prospective (nonrandomized) study the feasibility of 
controlled hypotension in candidates for open surgery and endovascular repair. 
However, to date, there is no prospective randomized controlled trial demonstrat-
ing the advantage of hypotensive hemostasis over standard resuscitation manage-
ment [10].
Resuscitation is generally initiated when aortic rupture is confirmed by ultra-
sound and/or CTA. In analogy to trauma patients, reducing the time from the initial 
event to having the bleeding under control in rAAA may increase the chance of 
survival [11]. Based on a Cochrane meta-analysis, there is no clear evidence on 
which type of fluid should be employed (crystalloids or colloids) in patients present-
ing with hemorrhagic shock. However, the lack of outcome differences made the 
authors advise the use of crystalloids for economic reasons [12]. If fluid administra-
tion is not sufficient to restore the arterial blood pressure or undesirable such as in 
the presence of a large retroperitoneal hematoma, vasopressor drugs may be 
employed in order to reduce the risk of tissue hypoperfusion. However, the use of 
vasopressors is justified only transiently and just to reach systolic arterial pressures 
of 80–90 mmHg [13]. If cardiac function is depressed, an inotropic agent should be 
utilized [14]. Control of corporeal temperature is another relevant measure that can 
influence not only arterial pressure but also acid-base status and coagulation. 
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Hypothermia (<35°) is associated with higher mortality and morbidity in patients 
presenting with hypotension in association with hemorrhagic shock [15]. In 1965 
Shaftan et al. reported that “Blood loss from an arterial injury is greatest in quantity 
and prolonged when fluids or vasopressors are given and least and shortest when 
either resuscitation is withheld or vasodilators are administrated” [16]. In fact, gen-
eral anesthesia, necessary for the open approach in rAAA, and the resulting vaso-
plegia following its induction require a high volume of fluids to achieve an adequate 
volume balance and blood pressure. This fluid load increases the risk of hemor-
rhage, hypothermia and coagulation disorders, and abdominal compartment syn-
drome. Moreover, general anesthesia with the use of myorelaxation decreases the 
abdominal wall tone and therefore may contribute to the transition from a contained 
to a frank aortic aneurysm rupture [17, 18].
 Hypotensive Hemostasis Protocol and Experience 
at the University Hospital Zurich (USZ)
The hypotensive hemostasis protocol at USZ is based on permissive hypovolemia 
and controlled hypotension. Permissive hypovolemia consists in minimizing the 
administration of fluids (crystalloids and/or colloids), whereas controlled hypoten-
sion implies active lowering of the blood pressure with vasodilators and/or beta- 
blockers in normotensive or hypertensive patients to a target systolic blood pressure 
<90 mmHg. In such patients, fluid infusion is restricted to a minimum just to keep 
the intravenous lines open.
In patients presenting with low blood pressure but who are otherwise hemody-
namically stable, some fluids (100–500 ml) may be administered to maintain a tar-
get systolic blood pressure of ≥70 mmHg. We define “stable” as a systolic blood 
pressure of any value that does not require an increase in the amount of fluids or 
vasoactive pressors/dilators to remain constant over a longer period of time (>5 min). 
In patients who are critically hypotensive or who are unstable or who get uncon-
scious, a bolus of 250 ml of fluid (colloid or crystalloid or blood) may be infused. 
In addition, vasoactive pressors may eventually be required to restore and/or main-
tain the systolic blood pressure around 70 mmHg. Even under such low blood pres-
sure circumstances, conversion to general anesthesia is not necessary as long as the 
patient maintains intact airway reflexes. Transfusion of blood cells, coagulation fac-
tors, and platelets is based on the respective guidelines. Briefly, hematocrit is main-
tained over 24 %, and transfusion of coagulation factors and/or platelets is based on 
blood samples and rotational thromboelastometry (ROTEM).
The pressure-lowering effects of vasodilators are often more pronounced in 
patients with hypovolemia. Drugs must therefore be titrated carefully to the desired 
effect. Short-acting vasoactive drugs have a limited effect with regard to time. In 
case of inadvertent over-dosage or intentional termination of the permissive hypo-
tension after achieving sufficient hemostasis, the hypotensive effect of the drugs 
will fade rapidly.
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 Vasoactive Drugs
Esmolol, a short-acting and selective adrenergic β1-receptor antagonist, decreases 
heart rate and contractility, is metabolized by red blood cell esterases, and has an 
elimination half-life of approximately 9 min. It can be titrated to effect by repetitive 
i.v. bolus doses of 100 μg/kg up to a dose of 500 μg/kg followed by continuous i.v. 
infusion up to 125 μg/kg/min. The target range of the heart rate is 60–80 bpm.
Glyceryl trinitrate (nitroglycerin), a vasodilator with more prominent effects on 
peripheral veins than on arteries, decreases the preload of the heart by pooling of 
blood in the venous system. The elimination half-life is 2–3 min. Onset of action is 
immediate by relaxation of smooth muscle cells following an increase of intracel-
lular concentrations of cyclic guanosine monophosphate (cGMP). Titration to effect 
is done by repetitive i.v. bolus doses of 25 μg up to 75–100 μg/min followed by a 
continuous i.v. infusion of up to 300 μg/min. Reflex tachycardia is a physiological 
response to decreased preload and can be counteracted by esmolol i.v.
After control of bleeding has been achieved in the operating room, all pressure- 
lowering drugs are discontinued, and hypovolemia is corrected as necessary. 
Appropriate fluid resuscitation is the base for vasoactive drugs to sufficiently raise 
systemic blood pressure to the desired level. Norepinephrine, acting primarily as a 
vasopressor, is the first choice, followed by epinephrine as second choice in case of 
profound shock and/or in order to enhance the cardiac contractility.
Norepinephrine (noradrenaline), a stimulator of both adrenergic α1/2-receptors 
and β1-receptors, raises the systemic blood pressure primarily by arterial vasocon-
striction to a lower extent by its positive inotropic and chronotropic effects. It has an 
immediate onset of action and a half-life of 2–3 min. An i.v. bolus of 0.1 μg/kg is 
repetitively given followed by a continuous i.v. infusion of 0.01–0.3 μg/kg/min 
(0.8–24 μg/min for an 80 kg patient).
In cases of persisting clinical and laboratory signs of arterial hypoperfusion after 
appropriate correction of hypovolemia and vasopressor support with norepineph-
rine 0.3 μg/kg/min, impaired cardiac function may be the underlying cause, and 
epinephrine should be considered to improve cardiac inotropy.
Epinephrine (adrenaline) stimulates adrenergic β1/2-receptors with a resulting 
increase in cardiac chrono- and inotropy at lower dosage (0.01–0.1 μg/kg/min i.v.) 
and adrenergic α1/2-receptors with progressive peripheral arterial vasoconstriction 
at higher dosage (0.1–0.3 μg/kg/min i.v.). It has an immediate onset of action and a 
half-life of 2–3 min. If epinephrine is needed as a bolus (0.1–0.2 μg/kg i.v.), cardio-
pulmonary resuscitation is usually imminent.
Hypovolemia must be repeatedly ruled out or corrected if high doses of nor-
adrenaline are infused, particularly if combined with epinephrine, since hypovole-
mic vasoconstriction may cause profound tissue ischemia and necrosis. Simple use 
of a central line pressure or wedge pressure measurement from a Swan-Ganz cath-
eter can help determine if the patient needs additional volume or pressor medica-
tions (Table 11.1).
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 Intra-aortic Balloon
Endoclamping of the aorta with a large-size compliant balloon such as Reliant® 
(Medtronic) or the Coda (Cook) has been shown to be useful in patients with unsta-
ble hemodynamics and/or those patients unresponsive to fluids and catecholamines 
(Fig. 11.1). Endoclamping can be used for both the endovascular and the surgical 
approach. In stable low-pressure patients, especially when a large retroperitoneal 
hematoma has been identified preoperatively, it can also be used during the EVAR 
procedure to avoid further volume increase of the hematoma. The balloon can be 
placed under local anesthesia, utilizing a long (preferably ≥40 cm) sheath for pre-
vention of caudal migration during and after inflation. To avoid balloon-related 
complications, the inflation site should be free of major atherosclerotic aortic dis-
ease or aneurysm. Moreover, as the balloon is placed superior to the major branches 
of the abdominal aorta, the duration of the balloon inflation should be kept as short 
as possible, since inflation brings about temporary renovisceral ischemia.
 Discussion
Based on the early positive experience and subsequent systematic follow-up of the 
patients at our center, we have routinely applied the principles of hypotensive 
hemostasis for nearly 20 years. The feasibility of EVAR in rAAA using hypotensive 
hemostasis, including permissive hypovolemia, controlled hypotension, and local 
anesthesia, was reported by our group in 2001 [19]. In this series of 21 patients, 
restricted volumes of fluids and erythrocyte transfusions were enough to maintain 
hemodynamic stability prior to the completion of EVAR (Fig. 11.2).
Fig. 11.1 Intraoperative angiogram. After 
placing a guide wire, an aortic balloon is 
delivered and inflated suprarenal (here 
supraceliac) to achieve proximal 
hemorrhage control
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Generally, most patients remain stable with preserved mental function at a sys-
tolic blood pressure of 70–90 mmHg. To achieve stable hemodynamics at this blood 
pressure level, very limited amounts of fluids and vasoactive pressors are necessary 
during EVAR under local anesthesia. As a first step, analgesia is optimized to 
decrease the sympathomimetic activity. Low dosages of opioids are used and titrated 
to the desired effect. In patients undergoing interventions under local anesthesia, 
special care must be taken not to abolish consciousness and risk compromising 
spontaneous breathing and the protective airway reflexes. Advantages of local anes-
thesia include the preservation of sympathetic tone, yielding improved hemody-
namic stability, preservation of muscle tone, and thereby the possibility to better 
contain the bleeding, and, in addition, any procedure under local anesthesia offers 
the best neurological monitoring. The main disadvantages are related to eventual 
acute loss of consciousness and an uncontrolled airway, suboptimal pain control, 
and the patient not lying still. Conversely, general anesthesia has the advantages of 
a controlled airway and optimal pain control. However, by using general anesthesia, 
most of the advantages of local anesthesia are lost, and it is more time-consuming 
when compared to local. If general anesthesia is required for an open operation, the 
patient should be fully prepped and draped prior to induction, and, ideally, an aortic 
occlusion balloon should first be placed under local anesthesia so that it can be 
inflated in cases of severe hypotension at any point prior to or during the 
procedure.
The use of hypotensive hemostasis was advocated by the clinical practice guide-
lines of the European Society for Vascular Surgery as it “might have a beneficial 
effect on the survival in cases of abdominal aortic aneurysm rupture.” To maintain 
blood pressure in a range of 50–100 mmHg was recommended [20]. Limitations of 
hypotensive hemostasis are related mainly to brain, heart, and kidney perfusion. The 
brain perfusion is self-regulated within the systolic blood pressure range of 
50–100 mmHg. The risk of cerebral hypoperfusion and thus ischemic stroke espe-
cially in patients with concomitant cerebrovascular disease should always be 
Fig. 11.2 Total amount of fluids and transfusions given preoperatively, intraoperatively, and post-
operatively. Fluids crystalloids and/or colloids, Ec erythrocytes, FFP fresh frozen plasma, Tc 
thrombocytes, (Modified from Lachet et al. [19])
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acknowledged. If the operation is conducted under local anesthesia, initial signs of 
cerebral hypoperfusion can be realized early, and cerebral perfusion is usually sat-
isfactory if the patient responds adequately to neurological stimuli and is communi-
cating verbally. Also, coronary perfusion may be at risk with low blood pressure. In 
patients with known coronary artery disease undergoing the procedure under local 
anesthesia, electrocardiographic and clinical signs of myocardial ischemia should 
be analyzed, whereas in patients operated under general anesthesia, transesophageal 
echocardiography should be considered. The kidneys generally have a fairly good 
tolerance of temporary ischemia. However, concurrent insults, such as contrast 
medium injection, increase the risk of renal injury. Urine output is a valid tool in the 
monitoring of the renal function.
In summary, aggressive fluid resuscitation in aorta rupture patients can be detri-
mental, as large-volume infusion can lead to further blood loss and hemodilution, 
coagulopathy, and hypothermia. Moreover, massive retroperitoneal bleeding may 
result in abdominal compartment syndrome with a high risk of further severe com-
plications and death. Finally, extensive transfusion of blood cells, thrombocytes, 
and/or coagulation factors may be accompanied by transfusion-related acute lung 
injury. To avoid such scenarios and/or complications, hypotensive hemostasis, 
including permissive hypovolemia and controlled hypotension, is advocated.
References
 1. Morrison CA, Carrick MM, Norman MA, Scott BG, Welsh FJ, Tsai P, et al. Hypotensive 
resuscitation strategy reduces transfusion requirements and severe postoperative coagulopathy 
in trauma patients with hemorrhagic shock: preliminary results of a randomized controlled 
trial. J Trauma. 2011;70(3):652–63.
 2. Bougle A, Harrois A, Duranteau J. Resuscitative strategies in traumatic hemorrhagic shock. 
Ann Intensive Care. 2013;3(1):1.
 3. Mayer D, Rancic Z, Veith FJ, Pecoraro F, Pfammatter T, Lachat M. How to diagnose and treat 
abdominal compartment syndrome after endovascular and open repair of ruptured abdominal 
aortic aneurysms. J Cardiovasc Surg. 2014;55(2):179–92.
 4. Vlaar AP, Hofstra JJ, Determann RM, Veelo DP, Paulus F, Kulik W, et al. The incidence, risk 
factors, and outcome of transfusion-related acute lung injury in a cohort of cardiac surgery 
patients: a prospective nested case–control study. Blood. 2011;117(16):4218–25.
 5. Andresen AF. Management of gastric hemorrhage. Modern Med. 1949;17(20):72–5.
 6. Akins CW, Buckley MJ, Daggett W, McIlduff JB, Austen WG. Acute traumatic disruption of 
the thoracic aorta: a ten-year experience. Ann Thorac Surg. 1981;31(4):305–9.
 7. Crawford ES. Ruptured abdominal aortic aneurysm. J Vasc Surg. 1991;13(2):348–50.
 8. Veith FJ, Ohki T. Endovascular approaches to ruptured infrarenal aorto-iliac aneurysms. 
J Cardiovasc Surg. 2002;43(3):369–78.
 9. Yilmaz N, Peppelenbosch N, Cuypers PW, Tielbeek AV, Duijm LE, Buth J. Emergency treat-
ment of symptomatic or ruptured abdominal aortic aneurysms: the role of endovascular repair. 
J Endovasc Ther. An Official Journal of the International Society of Endovascular Specialists. 
2002;9(4):449–57.
 10. van der Vliet JA, van Aalst DL, Schultze Kool LJ, Wever JJ, Blankensteijn JD. Hypotensive 
hemostatis (permissive hypotension) for ruptured abdominal aortic aneurysm: are we really in 
control? Vascular. 2007;15(4):197–200.
F. Pecoraro et al.
149
 11. Cothren CC, Moore EE, Hedegaard HB, Meng K. Epidemiology of urban trauma deaths: a 
comprehensive reassessment 10 years later. World J Surg. 2007;31(7):1507–11.
 12. Perel P, Roberts I. Colloids versus crystalloids for fluid resuscitation in critically ill patients. 
Cochrane Database Syst Rev. 2011(3):CD000567
 13. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving Sepsis 
Campaign: international guidelines for management of severe sepsis and septic shock: 2008. 
Crit Care Med. 2008;36(1):296–327.
 14. Kaye P, O'Sullivan I. Myocardial contusion: emergency investigation and diagnosis. Emerg 
Med J. 2002;19(1):8–10.
 15. Hoey BA, Schwab CW. Damage control surgery. Scand J Surg. SJS Official organ for the 
Finnish Surgical Society and the Scandinavian Surgical Society. 2002;91(1):92–103.
 16. Shaftan GW, Chiu CJ, Dennis C, Harris B. Fundamentals of physiologic control of arterial 
hemorrhage. Surgery. 1965;58(5):851–6.
 17. Kozek-Langenecker SA, Afshari A, Albaladejo P, Santullano CA, De Robertis E, Filipescu 
DC, et al. Management of severe perioperative bleeding: guidelines from the European Society 
of Anaesthesiology. Eur J Anaesthesiol. 2013;30(6):270–382.
 18. Bettex DA, Lachat M, Pfammatter T, Schmidlin D, Turina MI, Schmid ER. To compare gen-
eral, epidural and local anaesthesia for endovascular aneurysm repair (EVAR). Eur J Vasc 
Endovasc Surg. The Official Journal of the European Society for Vascular Surgery. 
2001;21(2):179–84.
 19. Lachat ML, Pfammatter T, Witzke HJ, Bettex D, Kunzli A, Wolfensberger U, et al. Endovascular 
repair with bifurcated stent-grafts under local anaesthesia to improve outcome of ruptured 
aortoiliac aneurysms. Eur J Vasc Endovasc Surg. The Official Journal of the European Society 
for Vascular Surgery. 2002;23(6):528–36.
 20. Moll FL, Powell JT, Fraedrich G, Verzini F, Haulon S, Waltham M, et al. Management of 
abdominal aortic aneurysms clinical practice guidelines of the European society for vascular 
surgery. Eur J Vasc Endovasc Surg. The Official Journal of the European Society for Vascular 
Surgery. 2011;41 Suppl 1:S1–58.
11 Hypotensive Hemostasis in Patients Presenting with Ruptured Aortic Aneurysm
